Oregon will initially focus on providing lower-cost therapies for people living with sickle cell disease, a genetic blood ...

The Centers for Medicare & Medicaid Services (“CMS”) recently released two proposed updates to Medicare payment rules that, if implemented, could ...

After decades of excruciating pain, a breakthrough sickle cell disease treatment made all the difference for one patient.

AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1 at AGC Inc.’s Yokohama Technical Center.

Fulcrum Therapeutics reports promising late-stage data for sickle cell drug pociredir, with notable hemoglobin improvements.

CRSP investors await the company's Q2 results with a focus on Casgevy sales growth and updates on gene-editing pipeline progress.

A groundbreaking new medical dataset is poised to revolutionize health care in Africa by improving chatbots' understanding of ...

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Vertex Pharmaceuticals ...

The gene editing market represents one of the most transformative sectors in modern biotechnology, fundamentally reshaping ...

Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched ...

To mark the NHS’ 75 th anniversary this year, NHS England partnered with the London College of Communication (LCC), part of the University of the Arts London, to provide students with real-life ...